Article Information
PubMed
Print ISSN
Online ISSN
History
- Received February 14, 2003
- Accepted May 22, 2003
- Published online August 18, 2003.
Article Versions
- Earlier version (May 23, 2003 - 11:51).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and
Experimental Therapeutics
Author Information
- Jasminder Sahi,
- Mark A. Milad,
- Xianxian Zheng,
- Kelly A. Rose,
- Hongbing Wang,
- Linda Stilgenbauer,
- Darryl Gilbert,
- Summer Jolley,
- Ralph H. Stern and
- Edward L. LeCluyse
- Departments of Pharmacokinetics, Dynamics, and Metabolism (J.S., K.A.R., L.S.), Clinical Pharmacokinetics and Pharmacodynamics (M.A.M.), Molecular Biology (X.Z.), and Experimental Medicine (R.H.S.), Pfizer Global Research and Development, Ann Arbor, Michigan; and Division of Drug Delivery and Disposition (H.W., D.G., S.J., E.L.L.), School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina
- Address correspondence to:
Dr. Jasminder Sahi, Pfizer Global Research and Development, 2800 Plymouth Rd., Ann Arbor MI 48105. E-mail: jasminder.sahi{at}pfizer.com
Statistics from Altmetric.com
Article usage
In this issue
Avasimibe Induces CYP3A4 and Multiple Drug Resistance Protein 1 Gene Expression through Activation of the Pregnane X Receptor
